Iovance Biotherapeutics, Inc. IOVA Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s common stock?
- Iovance Biotherapeutics, Inc. (IOVA) reported common stock of $18K in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s common stock changed year-over-year?
- Iovance Biotherapeutics, Inc.'s common stock increased by 28.6% year-over-year, from $14K to $18K.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s common stock has grown at a 23.2% compound annual growth rate (CAGR), from $6K to $17K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).